Fig. 3 | Scientific Reports

Fig. 3

From: Treatment of non-small cell lung cancer using chem-bioinformatics-driven engineering of exosomal cargo-vehicle for telmisartan and pioglitazone targeted-delivery

Fig. 3

PPARG gene Expression in transcript/million in LUAD based on histological subtypes (A), individual cancer stages (B), nodal metastasis (C), and TP53 mutation status (D), from TCGA samples. [NOS: Lung Adenocarcinoma-Not Otherwise Specified, Mixed: Lung Adenocarcinoma Mixed subtype, Clear Cell: Lung Clear Cell Adenocarcinoma, LBC-Non mucinous: Lung Bronchioloalveolar Carcinoma Non-mucinous, Solid Pattern Predominant: Lung Solid Pattern Predominant Adenocarcinoma, Acinar: Lung Acinar Adenocarcinoma, LBC-Mucinous: Lung Bronchioloalveolar Carcinoma Mucinous, Mucinous: Mucinous (Colloid) Carcinoma, Papillary: Lung Papillary Adenocarcinoma, Mucinous: Lung Mucinous Adenocarcinoma, Micropapillary: Lung Micropapillary Adenocarcinoma, Signet Ring: Lung Signet Ring Adenocarcinoma. N0: No regional lymph node metastasis, N1: Metastases in 1 to 3 axillary lymph nodes, N2: Metastases in 4 to 9 axillary lymph nodes, N3: Metastases in 10 or more axillary lymph nodes, nodal metastasis is not available for 1 sample, NX: cancer in nearby LN cannot be measured in 11 samples.].

Back to article page